Wynnstay Group PLC
18 July 2007
Wynnstay Group plc
(the 'Company')
Issue of equity
The Company announces the issue, in aggregate, of 39,911 new ordinary shares of
25p each in the Company ('Ordinary Shares'). The Ordinary Shares were issued as
follows:
- 24,000 Ordinary Shares pursuant to the exercise of options at
£1.1625 per share under the executive share option scheme;
- 9,386 Ordinary Shares at £2.60 per share in lieu of certain loan
note redemptions; and
- 6,075 Ordinary Shares at £0.25 per share pursuant to the employee
participation scheme.
Application has been made for the new Ordinary Shares to be admitted to trading
on AIM and dealings are expected to commence on 24 July 2007. The new Ordinary
Shares will rank pari passu with the existing Ordinary Shares in issue and
increase the number of shares in issue to 11,821,168.
For further enquiries please contact:
Paul Roberts, Wynnstay Group plc Tel: 01691 828 512
David Youngman, WH Ireland Limited Tel: 0161 832 2174
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.